Paper41226290
Construction of a Zebrafish Model of Cardiac Hypertrophy Caused by ATIC Gene Deletion and Preliminary Exploration of Aerobic Exercise Improvement.
Yang T and 8 others. Int J Mol Sci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Construction of a Zebrafish Model of Cardiac Hypertrophy Caused by ATIC Gene Deletion and Preliminary Exploration of Aerobic Exercise Improvement. Papers, record 41226290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41226290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Construction of a Zebrafish Model of Cardiac Hypertrophy Caused by ATIC Gene Deletion and Preliminary Exploration of Aerobic Exercise Improvement.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Physical Conditioning, Animal | Major topic |
| Cardiomegaly | Major topic |
| Gene Deletion | Major topic |
| Zebrafish Proteins | Major topic |
| Cardiomyopathy, Hypertrophic | Major topic |
| Animals | |
| Zebrafish | |
| Disease Models, Animal |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4232137 | An index of the contractile state of the myocardium in man. | J Clin Invest | 1968 | https://conductscience.org/library/papers/4232137 | PubMed |
| 2 | 21217817 | Establishing zebrafish as a novel exercise model: swimming economy, swimming-enhanced growth and muscle growth marker gene expression. | PLoS One | 2010 | https://conductscience.org/library/papers/21217817 | PubMed |
| 3 | 36255053 | A phenotype-based forward genetic screen identifies Dnajb6 as a sick sinus syndrome gene. | Elife | 2022 | https://conductscience.org/library/papers/36255053 | PubMed |
| 4 | 27504012 | FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice. | Diabetes | 2016 | https://conductscience.org/library/papers/27504012 | PubMed |
| 5 | 33615478 | Aerobic exercise ameliorates cardiac hypertrophy by regulating mitochondrial quality control and endoplasmic reticulum stress through M2 AChR. | J Cell Physiol | 2021 | https://conductscience.org/library/papers/33615478 | PubMed |
| 6 | 24608803 | Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension. | Mol Cells | 2014 | https://conductscience.org/library/papers/24608803 | PubMed |
| 7 | 36068540 | Identification and functional characterization of BICD2 as a candidate disease gene in an consanguineous family with dilated cardiomyopathy. | BMC Med Genomics | 2022 | https://conductscience.org/library/papers/36068540 | PubMed |
| 8 | 35436132 | Exercise-Induced Long Noncoding RNAs As New Players in Cardiac Hypertrophy. | Circulation | 2022 | https://conductscience.org/library/papers/35436132 | PubMed |
| 9 | 31029578 | Cardiac arrhythmias after renal I/R depend on IL-1β. | J Mol Cell Cardiol | 2019 | https://conductscience.org/library/papers/31029578 | PubMed |
| 10 | 34998670 | Disorders of purine biosynthesis metabolism. | Mol Genet Metab | 2022 | https://conductscience.org/library/papers/34998670 | PubMed |
| 11 | 25869206 | Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/25869206 | PubMed |
| 12 | 37237146 | Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. | Nat Rev Cardiol | 2023 | https://conductscience.org/library/papers/37237146 | PubMed |
| 13 | 34803509 | ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival. | Int J Biol Sci | 2021 | https://conductscience.org/library/papers/34803509 | PubMed |
| 14 | 33179964 | Human de novo purine biosynthesis. | Crit Rev Biochem Mol Biol | 2021 | https://conductscience.org/library/papers/33179964 | PubMed |
| 15 | 31221257 | Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/31221257 | PubMed |
| 16 | 28912181 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. | Circ Res | 2017 | https://conductscience.org/library/papers/28912181 | PubMed |
| 17 | 38362779 | FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System. | Circulation | 2024 | https://conductscience.org/library/papers/38362779 | PubMed |
| 18 | 36914085 | Exercise pretreatment alleviates neuroinflammation and oxidative stress by TFEB-mediated autophagic flux in mice with ischemic stroke. | Exp Neurol | 2023 | https://conductscience.org/library/papers/36914085 | PubMed |
| 19 | 32822717 | Exercise intolerance establishment in pulmonary hypertension: Preventive effect of aerobic exercise training. | Life Sci | 2020 | https://conductscience.org/library/papers/32822717 | PubMed |
| 20 | 38071832 | A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis. | Semin Arthritis Rheum | 2024 | https://conductscience.org/library/papers/38071832 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41226290
GET https://conductscience.org/api/papers/v1/41226290/references?page=2